NEW YORK (GenomeWeb) – NanoString Technologies reported after the close of the market Wednesday that its revenues for the fourth quarter of 2017 rose 40 percent year over year.

For the three months ended Dec. 31, 2017, total revenues grew to $35.2 million from $25.2 million in Q4 2016, beating the average Wall Street estimate of $31.3 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Women with breast or ovarian cancer living in medically underserved regions of the US are less likely to get recommended BRCA1 or BRCA2 genetic testing, according to a new study.

Three immunology researchers are to receive this year's Albany Medical Center Prize in Medicine and Biomedical Research, the Albany Times-Union reports.

In Genome Research this week: clonal evolution analysis of acute myeloid leukemia, computational pipeline to examine relationships between bacterial pathogens, and more.

Elephants may have "re-animated" a pseudogene to help stave off cancer, according to the New York Times.